Stockscreener 앱 받기
72.89
0.01%
-0.01
Avidity Biosciences Inc 주식(RNA)의 최신 뉴스
Avidity Biosciences prices $600M stock offering - MSN
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Avidity Biosciences (RNA) - The Globe and Mail
(RNA) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Key facts: JPMorgan raises concerns on Novartis outlook; Novartis to acquire Avidity - TradingView
Avidity Biosciences Announces Expected Record Date for Spin-Off - TradingView
Avidity Biosciences stock hits all-time high at 72.74 USD By Investing.com - Investing.com Australia
Avidity Biosciences receives FTC clearance for Novartis merger - MSN
Novartis (NVS) Acquisition of Avidity Biosciences Moves Forward - GuruFocus
Avidity Biosciences Sets February 15, 2026 as Record Date for Planned Spin-Off - geneonline.com
Avidity holders to get Atrium cardiology SpinCo shares in Novartis deal - stocktitan.net
Avidity Biosciences says record date set for February 12, 2026 for spin-off - marketscreener.com
Avidity Biosciences Says Record Date Set For February 12, 2026 For Spin-Off - TradingView
Avidity Biosciences Announces Share Distribution for Spin-Off - intellectia.ai
Avidity Biosciences (NASDAQ:RNA) Hits New 12-Month HighHere's What Happened - MarketBeat
Avidity Biosciences stock hits all-time high at 72.74 USD - Investing.com
New York State Common Retirement Fund Purchases 120,365 Shares of Avidity Biosciences, Inc. $RNA - MarketBeat
Atle Fund Management AB Makes New Investment in Avidity Biosciences, Inc. $RNA - MarketBeat
Halper Sadeh LLC Encourages TWO, RNA, CVBF, TBN Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.
Avidity Biosciences Sets February Vote on $72-per-Share Novartis Takeover and Cardiology Spin-Off - TipRanks
Risk Recap: Whats the fair value of Avidity Biosciences Inc stock2025 Investor Takeaways & Real-Time Volume Spike Alerts - baoquankhu1.vn
Price Action: Will Avidity Biosciences Inc announce a stock splitJuly 2025 Decliners & Growth Focused Stock Reports - baoquankhu1.vn
Mutual of America Capital Management LLC Trims Stake in Avidity Biosciences, Inc. $RNA - MarketBeat
EFG Asset Management North America Corp. Reduces Holdings in Avidity Biosciences, Inc. $RNA - MarketBeat
Avidity Biosciences, Inc. (RNA) Stock Analysis: A Biotech Powerhouse with 434% Revenue Growth and Promising Clinical Trials - DirectorsTalk Interviews
Aug Momentum: Will Avidity Biosciences Inc outperform tech stocksJuly 2025 Review & Stepwise Trade Execution Plans - baoquankhu1.vn
Avidity Biosciences CSO sells $473k in RNA stock By Investing.com - Investing.com South Africa
Avidity Biosciences CFO MacLean sells $329k in stock By Investing.com - Investing.com Australia
Avidity Biosciences CMO sells $354k in stock By Investing.com - Investing.com South Africa
Avidity Biosciences Insider Sold Shares Worth $473,388, According to a Recent SEC Filing - 富途资讯
Avidity Biosciences CEO Boyce sells $1.04 million in stock By Investing.com - Investing.com Canada
Avidity Biosciences (NASDAQ:RNA) Insider Sells $473,388.30 in Stock - MarketBeat
Avidity Biosciences (NASDAQ:RNA) Insider Sells $354,642.75 in Stock - MarketBeat
Avidity Biosciences (NASDAQ:RNA) CEO Sells $1,042,338.15 in Stock - MarketBeat
Avidity Biosciences (NASDAQ:RNA) Insider Teresa Mccarthy Sells 2,929 Shares - MarketBeat
Avidity Biosciences CMO sells $354k in stock - Investing.com
Avidity Biosciences CSO sells $473k in RNA stock - Investing.com
Avidity Biosciences stock hits all-time high at $72.70 By Investing.com - Investing.com Australia
Avidity Biosciences (NASDAQ:RNA) Reaches New 12-Month HighHere's What Happened - MarketBeat
Avidity Biosciences stock hits all-time high at $72.70 - Investing.com
Weekly Earnings: Can Kosmos Energy Ltd expand into new marketsQuarterly Performance Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Retail Trends: Is Avidity Biosciences Inc a cyclical or defensive stockJuly 2025 Rallies & Low Volatility Stock Recommendations - baoquankhu1.vn
Avidity reports FTC granted request for early termination of HSR waiting period - MSN
Avidity Biosciences, Inc. (RNA) Stock Analysis: Exploring the Biotech Firm’s 434% Revenue Growth and Future Prospects - directorstalkinterviews.com
Avidity Biosciences CFO sells $93,985 in stock - MSN
Can Avidity Biosciences Inc continue delivering strong returnsTrade Ideas & Pattern Based Trade Signal System - baoquankhu1.vn
Aug PostEarnings: Can Avidity Biosciences Inc outperform in the next rallyJuly 2025 Volume & AI Driven Stock Price Forecasts - baoquankhu1.vn
0.10%
7.16%
자본화:
|
볼륨(24시간):